Currently Viewing:
Newsroom
Currently Reading
What We're Reading: States to Recalibrate Hospital Payments; Mumps Outbreak; Tuberculosis Eradication Plan
March 21, 2019 – AJMC Staff
Novo Nordisk Seeks Oral Semaglutide Approval, CV Indications on New Drug and Injectable
March 21, 2019 – Mary Caffrey and Samantha DiGrande
Continuing Systemic Treatment in Cutaneous T-cell Lymphoma Associated With Lower Healthcare Costs
March 20, 2019 – Mary Caffrey
Genomic Testing Can Reduce Costs by $6600 for Certain Patients With Breast Cancer
March 20, 2019 – Laura Joszt
Adherence to COPD Treatment Lower With 3 Inhalers Compared With 2
March 20, 2019 – Jaime Rosenberg
CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection
March 20, 2019 – Wallace Stephens
What We're Reading: Postpartum Depression Drug Approval; Marijuana and Psychosis; Mississippi Abortion Bill
March 20, 2019 – AJMC Staff
AHIP, Employer Groups Seek Congressional Action on Surprise Medical Bills
March 19, 2019 – Allison Inserro
The Current Landscape of CGRP Inhibitor Coverage
March 19, 2019 – Samantha DiGrande

Study Tries to Pinpoint Factors Predicting Pain After Breast Cancer Surgery

Allison Inserro
As with other kinds of surgery, patients undergoing operations for breast cancer can experience persistent postsurgical pain, which can negatively affect quality of life. Researchers in Tokyo conducted a study to see if they could determine the predictive value and accuracy of an acute pain trajectory, measured by pain intensity at 1 day after the surgery and pain prevalence at 6 months later.
As with other kinds of surgery, patients undergoing operations for breast cancer can experience persistent postsurgical pain, which can negatively affect quality of life. Researchers in Tokyo conducted a study to see if they could determine the predictive value and accuracy of an acute pain trajectory, measured by pain intensity at 1 day after the surgery and pain prevalence at 6 months later.

Female patients scheduled for breast cancer surgery were eligible for this study. Patients were questioned about pain intensity daily during the 7 days after surgery. Presence of pain, its location, and its intensity, as well as responses to the Japanese version of the QoR-40 survey, which measures quality of recovery, were determined in an interview prior to surgery and at 6 months after the surgery.

Acute pain trajectory was determined by a group-based trajectory modeling (GBTM) analysis that was based on pain intensity at 1 to 7 days after surgery. GBTM is a statistical method that can be used to determine the number and characteristics of the trajectory clusters for individuals who will have a similar outcome progression over time. In this study, researchers used GBTM analysis to establish clusters of trajectories representing the progression of acute pain after breast cancer surgery. The 3-cluster model (mild, moderate, and severe pain) was considered to be the most statistically appropriate model for the acute pain trajectory.

A total of 123 participants completed the 6-month follow-up. Each patient underwent either breast-conserving surgery or a mastectomy. All patients underwent surgery while under general anesthesia. All patients treated with breast-conserving surgery underwent whole-breast irradiation. None of the patients received neuraxial or peripheral nerve blockade. Patients with a high risk of recurrence were treated with either pre- or postoperative chemotherapy.

Pain intensity at the site of surgery was assessed every day from 1 to 7 days after the surgery. All participants underwent postsurgical rehabilitation in order to facilitate arm movement by a physical therapist and/or nurse.

Predictive value of the acute pain trajectory for the presence of pain at 6 months after the surgery was assessed by a logistic regression model. The predictive value was compared with pain intensity at 1 day after the surgery. After 6 months, 51.2% and 8.9% of participants reported pain and severe pain, respectively.

The severe pain cluster in the acute pain trajectory was associated with the presence of pain at 6 months after the surgery (P <.001). The adjusted odds ratio of the severe pain cluster (9.40) was larger than that of the moderate pain cluster (2.31) (P <.001 and P = .092, respectively).

The authors said classification of patients according to the acute pain trajectory, when compared with the classification according to pain intensity at 1 day after the surgery, made it possible to predict with better precision those patients who will develop persistent postsurgical pain.

They also said that radiation therapy and chemotherapy have been previously recognized as risk factors for persistent pain after breast cancer surgery. In this study, radiation therapy but not chemotherapy was identified as an independent factor that was associated with pain at 6 months after surgery.

Reference

Okamoto A, Yamasaki M, Yokota I, et al. Classification of acute pain trajectory after breast cancer surgery identifies patients at risk for persistent pain: a prospective observational study. [published online October 5, 2018]. J Pain Res. doi: 10.2147/JPR.S171680.

Related Articles

Twice-Yearly MRIs Superior at Finding Early Breast Cancer in High-Risk Women
Are Integrated Practice Units Working in Breast Cancer Clinical Pathways?
Adherence to NCCN Breast Cancer Guidelines Improves Outcomes
Study Examines Impact of Deviating From NCCN Guidelines for Metastatic Breast Cancer
Cancer Care Pathway Utilization Reduces Cost in Breast Cancer
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!